{"id":5040,"date":"2021-09-28T15:19:36","date_gmt":"2021-09-28T12:19:36","guid":{"rendered":"https:\/\/www.klimik.org.tr\/koronavirus\/?p=5040"},"modified":"2021-09-28T15:19:36","modified_gmt":"2021-09-28T12:19:36","slug":"prof-dr-serap-simsek-yavuz-asi-olmayanlara-kisitlama-artmali","status":"publish","type":"post","link":"https:\/\/www.klimik.org.tr\/koronavirus\/prof-dr-serap-simsek-yavuz-asi-olmayanlara-kisitlama-artmali\/","title":{"rendered":"Prof. Dr. Serap \u015eim\u015fek-Yavuz: A\u015f\u0131 Olmayanlara K\u0131s\u0131tlama Artmal\u0131"},"content":{"rendered":"<p class=\"detail__spot\"><img decoding=\"async\" loading=\"lazy\" class=\"size-full wp-image-34624 alignleft\" src=\"https:\/\/www.klimik.org.tr\/wp-content\/uploads\/2014\/11\/BirG\u00fcn-logo.jpg\" alt=\"\" width=\"100\" height=\"27\" \/><strong>Vaka say\u0131lar\u0131 26 bine yakla\u015ft\u0131. T\u00fcrk Klinik Mikrobiyoloji ve \u0130nfeksiyon Hastal\u0131klar\u0131 (KL\u0130M\u0130K) Derne\u011fi\u00a0 Ba\u015fkan\u0131 ve Bilim Kurulu \u00dcyesi Prof. Dr. Serap \u015eim\u015fek-Yavuz, a\u015f\u0131 olmayanlara k\u0131s\u0131tlaman\u0131n artmas\u0131 gerekti\u011fini vurguluyor: \u0130nsanlar\u0131 a\u015f\u0131lama i\u00e7in bilgilendirirken zorlay\u0131c\u0131 \u00f6nlemler de al\u0131nmal\u0131.<\/strong><\/p>\n<p>COVID-19 vaka say\u0131s\u0131 yakla\u015f\u0131k 26 bine y\u00fckseldi. A\u015f\u0131lama ise hen\u00fcz yeterli seviyede de\u011fil. 14-20 Haziran haftas\u0131nda g\u00fcnde ortalama 1.1 milyon doz a\u015f\u0131 yap\u0131l\u0131rken 14-20 Eyl\u00fcl haftas\u0131nda ise bu say\u0131 454 bine kadar d\u00fc\u015ft\u00fc. KL\u0130M\u0130K Derne\u011fi Ba\u015fkan\u0131 ve Bilim Kurulu \u00dcyesi Prof. Dr. Serap \u015eim\u015fek-Yavuz ile a\u015f\u0131laman\u0131n geldi\u011fi son durumu, a\u015f\u0131 kar\u015f\u0131tl\u0131\u011f\u0131na dair konu\u015ftuk.<\/p>\n<p><strong>Vaka say\u0131lar\u0131 uzun s\u00fcredir 25 bin, g\u00fcnl\u00fck \u00f6l\u00fcm say\u0131lar\u0131 ise 250 civar\u0131nda seyrediyor. Bunlar\u0131n yan\u0131nda bir de a\u015f\u0131lama oranlar\u0131n\u0131n azald\u0131\u011f\u0131n\u0131 g\u00f6r\u00fcyoruz. Bu tabloyu nas\u0131l de\u011ferlendiriyorsunuz?<\/strong><br \/>\n\u0130nfeksiyonun yay\u0131l\u0131m\u0131n\u0131 durdurabilmek ve \u00f6l\u00fcmleri azaltabilmek i\u00e7in y\u00fczde 70-80 civar\u0131nda bir a\u015f\u0131lama oran\u0131na ula\u015fmam\u0131z laz\u0131m. \u015eu anda da o orana ula\u015fm\u0131\u015f de\u011filiz. Her ne kadar a\u015f\u0131l\u0131larda \u00f6l\u00fcm oran\u0131 ve hastaneye yat\u0131\u015f oran\u0131 az olsa da a\u015f\u0131lanmayan \u00e7ok fazla insan oldu\u011fu i\u00e7in onlarda infeksiyon g\u00f6r\u00fclmeye devam ediyor. Okullar a\u00e7\u0131ld\u0131, t\u00fcm i\u015fyerleri a\u00e7\u0131k ve neredeyse hayat normal \u015fekilde devam ediyor. Daha fazla insan\u0131 kaybetmemek i\u00e7in bula\u015f\u0131 azaltacak \u00f6nlemler alarak bu k\u0131\u015f\u0131 ge\u00e7irmeliyiz.<\/p>\n<p><strong>Bu k\u0131\u015f nas\u0131l bir tablo bizi bekliyor?<\/strong><br \/>\nHer \u015fey a\u015f\u0131lamay\u0131 ne kadar artt\u0131rabilece\u011fimize ba\u011fl\u0131. Aksi takdirde b\u00f6yle devam ederse vaka say\u0131lar\u0131 art\u0131\u015f g\u00f6sterebilir ve \u00f6l\u00fcm say\u0131lar\u0131 da artabilir diye d\u00fc\u015f\u00fcn\u00fcyorum. \u0130nfeksiyona, yani virusa duyarl\u0131 olan b\u00fcy\u00fck bir grup var. Bu grup a\u015f\u0131lanmam\u0131\u015f oldu\u011fu i\u00e7in her t\u00fcrl\u00fc k\u00f6t\u00fc sonu\u00e7tan etkilenebilirler.<\/p>\n<p><strong>COVID-19 nedeniyle a\u015f\u0131 olmayan hamilelerin \u00f6l\u00fcm oranlar\u0131n\u0131n artt\u0131\u011f\u0131 ifade ediliyor. Hamileler salg\u0131ndan nas\u0131l etkileniyor?<\/strong><br \/>\nGebeler kesinle risk grubunda. T\u00fcrkiye\u2019de de kullan\u0131lan a\u015f\u0131lar d\u00fcnyada milyonlarca doz yap\u0131lm\u0131\u015f ne gebeye ne de bebe\u011fine olumsuz bir etkisi olmad\u0131\u011f\u0131 g\u00f6sterilmi\u015f a\u015f\u0131lar. Bu a\u015f\u0131lar gebeyi infeksiyona kar\u015f\u0131 koruyor. O nedenle hangi evrede olursa olsun gebelerin veya gebe kalmay\u0131 d\u00fc\u015f\u00fcnenlerin a\u015f\u0131lanmas\u0131n\u0131 \u00f6neriyoruz. A\u015f\u0131larla ilgili kafalar\u0131ndaki yanl\u0131\u015f d\u00fc\u015f\u00fcncelerin giderilmesi gerekiyor. Gebelerin a\u015f\u0131lanmas\u0131na \u00f6zel \u00f6nem vermek gerekiyor. \u015eu ana a\u015f\u0131lamada \u00f6ncelik verilmesi gereken grup hem gebeler, hem de yanl\u0131\u015f bilgilendirilmi\u015f ve a\u015f\u0131 teredd\u00fct\u00fc ya\u015fayan ki\u015filer asl\u0131nda. \u00c7\u00fcnk\u00fc onlar yanl\u0131\u015f bilgilendikleri i\u00e7in a\u015f\u0131 olmuyorlar.<\/p>\n<p><strong>\u0130ki doz BioNTech olanlara hat\u0131rlatma a\u015f\u0131s\u0131 yap\u0131lacak m\u0131?<\/strong><br \/>\nG\u00fcndeme gelecek. \u00d6zellikle 65 ya\u015f \u00fcst\u00fc ile sa\u011fl\u0131k \u00e7al\u0131\u015fanlar\u0131 gibi \u00f6nde \u00e7al\u0131\u015fan gruplara ek dozlar \u00e7\u0131km\u0131\u015ft\u0131. 65 ya\u015f s\u00fct\u00fc olup sadece iki doz BioNTech olanlara de alt\u0131nc\u0131 aydan sonra ek bir doz yap\u0131lmas\u0131 gerekecek. Sinovac a\u015f\u0131s\u0131nda \u00fc\u00e7\u00fcnc\u00fc dozun \u00f6nerilme nedeni a\u011f\u0131r hastal\u0131\u011f\u0131 belli bir s\u00fcre sonra \u00f6nleyemeyecek hale gelmesiydi. BioNTech a\u015f\u0131s\u0131 65 ya\u015f\u0131n alt\u0131nda a\u011f\u0131r hastal\u0131\u011f\u0131 \u00f6nlemeye devam ediyor. Esas ama\u00e7 a\u015f\u0131lamada a\u011f\u0131r hastal\u0131\u011f\u0131 ve \u00f6l\u00fcm\u00fc engellemek.<\/p>\n<p><strong>VER\u0130LER \u015eEFFAFLIKLA PAYLA\u015eILMALI<\/strong><\/p>\n<p>Sa\u011fl\u0131k Bakanl\u0131\u011f\u0131 bir\u00e7ok veriyi gizlerken T\u00dc\u0130K de \u00f6l\u00fcm verilerini a\u00e7\u0131klamad\u0131. Ayr\u0131ca Sa\u011fl\u0131k Bakanl\u0131\u011f\u0131 sa\u011fl\u0131k istatistikleri y\u0131ll\u0131\u011f\u0131n\u0131 yay\u0131mlamad\u0131. Bunlar\u0131 nas\u0131l de\u011ferlendiriyorsunuz?<br \/>\nSalg\u0131nda t\u00fcm veriler \u015feffaf bir \u015fekilde, g\u00fcn\u00fc g\u00fcn\u00fcne, anl\u0131k olarak herkesle ve t\u00fcm detay\u0131yla payla\u015f\u0131lmal\u0131. Salg\u0131n\u0131 ancak en iyi bu \u015fekilde y\u00f6netebilirsiniz ve g\u00fcven de en iyi bu \u015fekilde sa\u011flanabiliyor. Mesela hangi a\u015f\u0131yla ne kadar korunduk? Bu veri \u00e7ok \u00f6nemli. Bunlar\u0131 t\u00fcm detay\u0131yla g\u00f6rmek herkesin hakk\u0131. Sonu\u00e7ta a\u015f\u0131n\u0131n etkinli\u011fini g\u00f6stermek insanlar\u0131 a\u015f\u0131 olmaya motive eden bir \u015feydir. Bu y\u00fczden verilerin payla\u015f\u0131lmas\u0131 \u00e7ok \u00f6nemli.<\/p>\n<p><strong>A\u015f\u0131 olmayanlara uygulanan k\u0131s\u0131tlamalar sizce yeterli mi?<\/strong><br \/>\nBaz\u0131 meslek gruplar\u0131na a\u015f\u0131 zorunlu olmal\u0131 ve a\u015f\u0131 olmayanlar i\u00e7in s\u0131n\u0131rlamalar biraz daha artt\u0131r\u0131lmal\u0131. \u0130nsanlar\u0131 a\u015f\u0131lama i\u00e7in bilgilendirirken zorlay\u0131c\u0131 \u00f6nlemler de al\u0131nmal\u0131. A\u015f\u0131n\u0131n g\u00fcvenli ve etkili oldu\u011funu biliyoruz \u00e7\u00fcnk\u00fc.<\/p>\n<p><strong>A\u015f\u0131 kar\u015f\u0131tlar\u0131 \u0130stanbul ve Ankara\u2019da miting yapt\u0131. Ne d\u00fc\u015f\u00fcn\u00fcyorsunuz bu mitingler hakk\u0131nda?<\/strong><br \/>\nOnlar\u0131n hangi d\u00fcnyada ya\u015fad\u0131\u011f\u0131n\u0131 bilmiyorum. A\u015f\u0131 kar\u015f\u0131tlar\u0131 \u00e7ok fazla de\u011filler ama \u00e7ok ses \u00e7\u0131kar\u0131yorlar. G\u00f6r\u00fcn\u00fcr olmak konusunda ustalar ve \u00e7ok masum da de\u011filler. Onlara bir \u015fey anlatabilmek m\u00fcmk\u00fcn de de\u011fil. Bizim hedefimiz onlar\u0131n kand\u0131rd\u0131klar\u0131 ve teredd\u00fct ya\u015fayan insanlar.<\/p>\n<p><strong>12 YA\u015e \u00dcST\u00dc HIZLICA A\u015eILANMALI<\/strong><\/p>\n<p><strong>Okullar a\u00e7\u0131ld\u0131 ve \u00e7ocuklar\u0131n aras\u0131nda bir virus yay\u0131l\u0131yor. Okullar\u0131n durumu nas\u0131l buluyorsunuz?<\/strong><br \/>\nD\u00fcnyan\u0131n her yerinde COVID-19\u2019a yakalanan \u00e7ocuklar\u0131n oran\u0131 art\u0131yor. \u00c7\u00fcnk\u00fc sadece eri\u015fkinler a\u015f\u0131lan\u0131yor. O nedenle \u00e7ocuklarda da a\u015f\u0131y\u0131 \u00f6ne \u00e7\u0131karmam\u0131z gerekiyor. \u015eu an 12 ya\u015f \u00fcst\u00fc a\u015f\u0131 olabilir ve onlar\u0131 h\u0131zl\u0131ca a\u015f\u0131lamam\u0131z gerek. Okullar\u0131 a\u00e7\u0131k tutabilmek i\u00e7in de bu \u00e7ok \u00f6nemli. 12 ya\u015f\u0131nda k\u00fc\u00e7\u00fck \u00e7ocu\u011fu olan ebeveynlerin de a\u015f\u0131lanmas\u0131 gerekiyor. Evdeki ve okuldaki herkes a\u015f\u0131l\u0131 olursa \u00e7ocuklar da korunabilirler. Bir kere \u00fcniversite \u00f6\u011frencilerinin hepsinin a\u015f\u0131 olmas\u0131 gerekiyor. \u00dcniversitelerin a\u00e7\u0131k kalabilmesi i\u00e7in bu \u00e7ok \u00f6nemli.<\/p>\n<p><strong>12 ya\u015f\u0131n alt\u0131ndaki \u00e7ocuklar i\u00e7in a\u015f\u0131 g\u00fcvenli mi?<\/strong><br \/>\nB\u00fct\u00fcn d\u00fcnyada 12 ya\u015f\u0131n alt\u0131 i\u00e7in de a\u015f\u0131 konu\u015fuluyor. A\u015f\u0131lar\u0131n 12 ya\u015f alt\u0131 i\u00e7in de g\u00fcvenli ve etkili oldu\u011funu kan\u0131tlamak i\u00e7in \u00e7al\u0131\u015fmalar yap\u0131l\u0131yor ve a\u015f\u0131lar\u0131n etkili, g\u00fcvenli oldu\u011fu g\u00f6sterildikten sonra k\u00fc\u00e7\u00fck \u00e7ocuklara da a\u015f\u0131 yap\u0131lacak. \u015eu anda, hen\u00fcz hakemli dergilerde yay\u0131mlanmam\u0131\u015f baz\u0131 ara\u015ft\u0131rmalar mRNA a\u015f\u0131lar\u0131n\u0131n daha d\u00fc\u015f\u00fck dozunun k\u00fc\u00e7\u00fck \u00e7ocuklarda yeti\u015fkinlerdeki etkiyi g\u00f6sterdi\u011fini, etkili ve g\u00fcvenli oldu\u011funu g\u00f6sterdi. Bu ara\u015ft\u0131rmalar\u0131n sonu\u00e7lar\u0131 yay\u0131mlan\u0131nca daha detayl\u0131 g\u00f6rece\u011fiz. Bu sonu\u00e7lar\u0131n ilgili kurulu\u015flar taraf\u0131ndan incelenip uygun bulunmas\u0131 halinde 12 ya\u015f alt\u0131na da onay verilecektir diye d\u00fc\u015f\u00fcn\u00fcyorum. 12 ya\u015f alt\u0131n\u0131n a\u015f\u0131ya ula\u015fmas\u0131 bu y\u0131l\u0131n sonuna kadar olmayacakt\u0131r, \u00f6n\u00fcm\u00fczdeki y\u0131l anca olabilir diye tahmin ediyorum. Dolay\u0131s\u0131yla \u015fu a\u015famada k\u00fc\u00e7\u00fckleri, yeti\u015fkin insanlar\u0131 a\u015f\u0131layarak korumam\u0131z laz\u0131m.<\/p>\n<p><a href=\"https:\/\/www.birgun.net\/haber\/asi-olmayanlara-kisitlama-artmali-360186\"><strong>Haber \u0130\u00e7in T\u0131klay\u0131n\u0131z<\/strong><\/a><\/p>\n<div id=\"stats\" class=\"detail__share\">\n<div class=\"addthis_inline_share_toolbox\" data-url=\"https:\/\/www.birgun.net\/haber\/asi-olmayanlara-kisitlama-artmali-360186\" data-title=\"A\u015f\u0131 olmayanlara k\u0131s\u0131tlama artmal\u0131\" data-description=\"Vaka say\u0131lar\u0131 26 bine yakla\u015ft\u0131. Bilim Kurulu \u00dcyesi Prof. Dr. Serap \u015eim\u015fek Yavuz, a\u015f\u0131 olmayanlara k\u0131s\u0131tlaman\u0131n artmas\u0131 gerekti\u011fini vurguluyor: \u0130nsanlar\u0131 a\u015f\u0131lama\">\n<div id=\"atstbx\" class=\"at-resp-share-element at-style-responsive addthis-smartlayers addthis-animated at4-show\" role=\"region\" aria-labelledby=\"at-9bb5d9fc-07c5-488c-bac8-438f7ab7fc61\"><\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Vaka say\u0131lar\u0131 26 bine yakla\u015ft\u0131. T\u00fcrk Klinik Mikrobiyoloji ve \u0130nfeksiyon Hastal\u0131klar\u0131 (KL\u0130M\u0130K) Derne\u011fi\u00a0 Ba\u015fkan\u0131 ve Bilim Kurulu \u00dcyesi Prof. Dr. Serap \u015eim\u015fek-Yavuz, a\u015f\u0131 olmayanlara k\u0131s\u0131tlaman\u0131n artmas\u0131 gerekti\u011fini vurguluyor: \u0130nsanlar\u0131 a\u015f\u0131lama i\u00e7in bilgilendirirken zorlay\u0131c\u0131 \u00f6nlemler de al\u0131nmal\u0131. COVID-19 vaka say\u0131s\u0131 yakla\u015f\u0131k 26 bine y\u00fckseldi. A\u015f\u0131lama ise hen\u00fcz yeterli seviyede de\u011fil. 14-20 Haziran haftas\u0131nda g\u00fcnde ortalama 1.1 milyon doz a\u015f\u0131 yap\u0131l\u0131rken 14-20 Eyl\u00fcl haftas\u0131nda ise bu say\u0131 454 bine kadar d\u00fc\u015ft\u00fc. KL\u0130M\u0130K Derne\u011fi Ba\u015fkan\u0131 ve Bilim Kurulu \u00dcyesi Prof. Dr. Serap \u015eim\u015fek-Yavuz ile a\u015f\u0131laman\u0131n geldi\u011fi son durumu, a\u015f\u0131 kar\u015f\u0131tl\u0131\u011f\u0131na dair konu\u015ftuk. Vaka say\u0131lar\u0131 uzun s\u00fcredir 25 bin, g\u00fcnl\u00fck \u00f6l\u00fcm say\u0131lar\u0131 ise 250 [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":5041,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[1],"tags":[],"_links":{"self":[{"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/posts\/5040"}],"collection":[{"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/comments?post=5040"}],"version-history":[{"count":1,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/posts\/5040\/revisions"}],"predecessor-version":[{"id":5042,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/posts\/5040\/revisions\/5042"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/media\/5041"}],"wp:attachment":[{"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/media?parent=5040"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/categories?post=5040"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/tags?post=5040"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}